About Sms Pharmaceuticals
Sms Pharmaceuticals is a company based in Hyderabad (India) founded in 1990. The company has 1,870 employees as of March 31, 2024. Sms Pharmaceuticals offers products and services including API Manufacturing and Intermediates. Sms Pharmaceuticals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 1870 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sms Pharmaceuticals Limited
-
Annual Revenue
$91.18 M (USD)10.31as on Mar 31, 2025
-
Net Profit
$8.09 M (USD)38.75as on Mar 31, 2025
-
EBITDA
$16.15 M (USD)19.83as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1870
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sms Pharmaceuticals
Sms Pharmaceuticals is a publicly listed company on the NSE with ticker symbol SMSPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sms Pharmaceuticals
Sms Pharmaceuticals offers a comprehensive portfolio of products and services, including API Manufacturing and Intermediates.
Manufactures Active Pharmaceutical Ingredients for global markets
Produces intermediates for pharmaceutical applications
People of Sms Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Sms Pharmaceuticals
Detailed funding history for Sms Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sms Pharmaceuticals
Investment portfolio details for Sms Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sms Pharmaceuticals
Detailed financials for Sms Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sms Pharmaceuticals Comparisons
Peer comparison for Sms Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sms Pharmaceuticals
Sms Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Sms Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sms Pharmaceuticals
Complete news archive for Sms Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sms Pharmaceuticals
Sms Pharmaceuticals was founded in 1990.
Sms Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Sms Pharmaceuticals is 1,870.
Annual revenue of Sms Pharmaceuticals is $91.18M as on Mar 31, 2025.
SMS Pharmaceuticals was established in 1990 in Hyderabad, India, initially as a single-product manufacturer in the pharmaceutical sector. APIs and intermediates are produced for various therapeutic segments from multiple locations. Four facilities have received approvals from FDA, PMDA, EUGMP (Germany), KFDA, TGA, and COFEPRIS (Mexico). Contract research services are offered, with products reaching over 70 countries. Process reactions and reactor volumes up to 15KL are managed.
Sms Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Sms Pharmaceuticals offers API Manufacturing and Intermediates.
Yes, Sms Pharmaceuticals is publicly traded on NSE under the ticker symbol SMSPHARMA.
The ticker symbol of Sms Pharmaceuticals is SMSPHARMA on NSE.